What's new? Log in Free sign up

Filing search / Legend Biotech Corporation / "Targets"

Search information

Legend Biotech Corporation

Companies

"Targets"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

36 results

Newest first Best match first

LEGN Legend Biotech Corporation

Current report (foreign)

(including, without limitation, any applicable performance targets or criteria with respect thereto); and the grant or exercise price per share for any

LEGN Legend Biotech Corporation

Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights

lymphoma; RRMM: relapsed or refractory multiple myeloma; SCLC: small cell lung cancer TARGETS: BCMA: B-cell maturation antigen; DLL3: delta-like ligand 3

LEGN Legend Biotech Corporation

Annual report (foreign)

lead product, cilta-cel, is an autologous CAR-T cell therapy that targets the BCMA, which is a highly expressed protein in a number of hematologic … , there are a number of key challenges in developing CAR-T and CAR-NK cell therapies. Selecting an appropriate tumor antigen target: The antigen targets

19 Mar 24

7:02am

LEGN Legend Biotech Corporation

Annual report (foreign)

lead product, cilta-cel, is an autologous CAR-T cell therapy that targets the BCMA, which is a highly expressed protein in a number of hematologic … targets that are recognized by CAR-T or CAR-NK cells are membrane-bound cell surface proteins. Limited distribution in normal tissue, over

29 Mar 23

7:43pm

LEGN Legend Biotech Corporation

Legend Biotech Corporation 6-K

and, to the extent required by the Compensation Committee of the Company’s Board of Directors, the achievement of performance targets as established

Legend Biotech Corporation 6-K

Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board

jegxkqdobucf3p6se2

Legend Biotech Corporation Announces Proposed Public Offering

rclxtwi ii8jzeeivwg

Annual report (foreign)

31 Mar 22

8:02am

m9rf9r02 mk1tsjm

Legend Biotech Corporation 6-K

Legend Biotech Corporation Announces Proposed Public Offering

Legend Biotech Corporation 6-K

Legend Biotech Corp. 6-K

Legend Biotech Corp. 6-K

Legend Biotech Corp. 6-K

Legend Biotech Corporation 6-K

Legend Biotech Corporation 6-K

Legend Biotech Corporation 6-K

Current report (foreign)

9t0lm m80z9dk5lu

Legend Biotech Announces Advancement of Global Manufacturing Infrastructure

Prev
1
2
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.